Birdwatch Archive

Birdwatch Note

2023-05-19 23:42:36 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Claim that the antiviral drug remdesivir is killing people is baseless. Meta-analysis have demonstrated that Remdesivir is a safe therapeutic option https://healthfeedback.org/claimreview/claim-that-antiviral-drug-remdesivir-killing-people-is-baseless/ https://pubmed.ncbi.nlm.nih.gov/34323191/

Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1659648084488355840

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1659706149690658821
  • noteId - 1659706149690658821
  • participantId -
  • noteAuthorParticipantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31 Participant Details
  • createdAtMillis - 1684539756592
  • tweetId - 1659648084488355840
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Claim that the antiviral drug remdesivir is killing people is baseless. Meta-analysis have demonstrated that Remdesivir is a safe therapeutic option https://healthfeedback.org/claimreview/claim-that-antiviral-drug-remdesivir-killing-people-is-baseless/ https://pubmed.ncbi.nlm.nih.gov/34323191/

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-05-19 23:42:36 UTC
(1684539756592)		 1969-12-31 23:59:59 UTC
(-1)		 2023-05-20 02:39:09 UTC
(1684550349297)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)
2023-05-19 23:42:36 UTC
(1684539756592)		 1969-12-31 23:59:59 UTC
(-1)		 2023-05-31 02:39:52 UTC
(1685500792003)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-05-19 19:30:28 -0500 Rating Details
2023-05-19 19:26:28 -0500 Rating Details
2023-05-19 19:13:33 -0500 Rating Details
2023-05-19 19:03:26 -0500 Rating Details
2023-05-19 18:53:21 -0500 Rating Details
2023-05-19 23:26:47 -0500 Rating Details
2023-05-20 06:45:10 -0500 Rating Details
2023-05-19 19:38:37 -0500 Rating Details
2023-05-20 01:40:11 -0500 Rating Details
2023-05-20 00:45:28 -0500 Rating Details
2023-05-20 01:13:45 -0500 Rating Details
2023-05-20 01:15:20 -0500 Rating Details
2023-05-20 00:59:01 -0500 Rating Details
2023-05-20 00:47:51 -0500 Rating Details
2023-05-20 06:17:46 -0500 Rating Details
2023-05-19 19:53:06 -0500 Rating Details
2023-05-19 23:56:18 -0500 Rating Details
2023-05-20 01:53:55 -0500 Rating Details
2023-05-20 08:31:30 -0500 Rating Details
2023-05-20 12:48:28 -0500 Rating Details
2023-05-20 00:08:13 -0500 Rating Details
2023-05-19 23:22:35 -0500 Rating Details
2023-05-19 19:44:23 -0500 Rating Details
2023-05-20 00:23:54 -0500 Rating Details
2023-05-19 23:29:44 -0500 Rating Details
2023-05-19 23:29:01 -0500 Rating Details
2023-05-19 23:36:43 -0500 Rating Details
2023-05-20 01:22:24 -0500 Rating Details
2023-05-19 22:07:40 -0500 Rating Details
2023-05-20 08:55:33 -0500 Rating Details
2023-05-20 00:26:47 -0500 Rating Details
2023-05-20 05:22:12 -0500 Rating Details
2023-05-20 00:51:52 -0500 Rating Details
2023-05-19 20:08:26 -0500 Rating Details
2023-05-19 23:28:50 -0500 Rating Details
2023-05-19 20:01:15 -0500 Rating Details
2023-05-20 08:27:08 -0500 Rating Details
2023-05-19 23:26:47 -0500 Rating Details
2023-05-20 06:45:10 -0500 Rating Details
2023-05-19 19:38:37 -0500 Rating Details
2023-05-20 01:40:11 -0500 Rating Details
2023-05-20 00:45:28 -0500 Rating Details
2023-05-20 01:13:45 -0500 Rating Details
2023-05-19 19:03:26 -0500 Rating Details
2023-05-20 01:15:20 -0500 Rating Details
2023-05-19 19:13:33 -0500 Rating Details
2023-05-20 00:59:01 -0500 Rating Details
2023-05-20 00:47:51 -0500 Rating Details
2023-05-20 06:17:46 -0500 Rating Details
2023-05-19 19:53:06 -0500 Rating Details
2023-05-19 23:56:18 -0500 Rating Details
2023-05-20 01:53:55 -0500 Rating Details
2023-05-20 08:31:30 -0500 Rating Details
2023-05-20 12:48:28 -0500 Rating Details
2023-05-21 15:45:35 -0500 Rating Details
2023-05-20 00:08:13 -0500 Rating Details
2023-05-19 23:22:35 -0500 Rating Details
2023-05-19 19:44:23 -0500 Rating Details
2023-05-19 19:30:28 -0500 Rating Details
2023-05-20 00:23:54 -0500 Rating Details
2023-05-19 23:29:44 -0500 Rating Details
2023-05-20 20:40:26 -0500 Rating Details
2023-05-19 23:29:01 -0500 Rating Details
2023-05-19 23:36:43 -0500 Rating Details
2023-05-20 01:22:24 -0500 Rating Details
2023-05-19 22:07:40 -0500 Rating Details
2023-05-20 08:55:33 -0500 Rating Details
2023-05-20 00:26:47 -0500 Rating Details
2023-05-20 05:22:12 -0500 Rating Details
2023-05-19 18:53:21 -0500 Rating Details
2023-05-20 00:51:52 -0500 Rating Details
2023-05-19 20:08:26 -0500 Rating Details
2023-05-19 23:28:50 -0500 Rating Details
2023-05-19 20:01:15 -0500 Rating Details
2023-05-19 19:26:28 -0500 Rating Details
2023-05-20 08:27:08 -0500 Rating Details
2023-05-25 22:30:51 -0500 Rating Details
2024-01-14 04:43:58 -0600 Rating Details
2024-09-21 03:24:14 -0500 Rating Details